Belpointe Asset Management LLC Buys 315 Shares of UnitedHealth Group Incorporated $UNH

Belpointe Asset Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,114 shares of the healthcare conglomerate’s stock after acquiring an additional 315 shares during the quarter. Belpointe Asset Management LLC’s holdings in UnitedHealth Group were worth $4,774,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently made changes to their positions in the company. Bayforest Capital Ltd grew its holdings in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its position in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares during the period. Copia Wealth Management purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $42,000. IAG Wealth Partners LLC bought a new position in UnitedHealth Group during the first quarter valued at $42,000. Finally, Investment Management Corp VA ADV purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $44,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 8.8%

UNH opened at $348.59 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business’s fifty day simple moving average is $289.41 and its 200 day simple moving average is $371.39. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The stock has a market cap of $315.71 billion, a PE ratio of 15.10, a P/E/G ratio of 2.09 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter last year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on UNH shares. Morgan Stanley cut their target price on shares of UnitedHealth Group from $342.00 to $325.00 and set an “overweight” rating for the company in a research report on Wednesday, August 20th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Sanford C. Bernstein raised their target price on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, JPMorgan Chase & Co. reduced their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research report on Wednesday, August 6th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $355.77.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.